Lung cancer is not commonly known to metastasize to the perirenal space, with only five such cases previously published. We present an unusual case of perirenal lung metastases manifesting as diffuse perinephric stranding which to our knowledge has not been described before.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1440-1673.2006.01570.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A rare case of Erdheim Chester disease.
Radiol Case Rep
December 2024
Central Unit of Radiology, University Hospital Center Ibn Rochd, School of Medicine and Pharmacy of Casablanca, Hassan II University, Casablanca, Morocco.
Article Synopsis
- Erdheim-Chester disease (ECD) is a rare condition classified as non-Langerhans cell histiocytosis, with limited cases documented in literature.
- A 53-year-old patient exhibited symptoms including xanthelasma (skin lesions), extreme fatigue, loss of appetite, and chronic breathing difficulties over five years.
- Imaging scans revealed significant signs of ECD, and a biopsy solidified the diagnosis, emphasizing the need for radiologists to recognize ECD signs to prevent misdiagnosis.
Does a postmortem redistribution affect the concentrations of the 7 azaindole-derived synthetic cannabinoid 5F-MDMB-P7AICA in tissues and body fluids following pulmonary administration to pigs?
Arch Toxicol
October 2024
Institute of Legal Medicine, Saarland University, Building 49.1, 66421, Homburg, Germany.
Many fatal intoxications have been reported in connection with the consumption of newer, highly potent synthetic cannabinoids. Yet, a possible postmortem redistribution (PMR) might complicate reliable interpretation of analytical results. Thus, it is necessary to investigate the PMR-potential of new synthetic cannabinoids.
View Article and Find Full Text PDF[A case of crizotinib-associated renal cysts].
Zhonghua Jie He He Hu Xi Za Zhi
April 2024
Department of Radiology, Zhuzhou Central Hospital/the Affiliated Zhuzhou Hospital Xiangya Medical College CSU, Zhuzhou 412007, China.
Crizotinib-associated renal cysts (CARC) are the development of new renal cysts or pre-existing renal cysts after the treatment with crizotinib. Most CARC disappear after crizotinib is stopped. A few CARC showed aggressive behavior that could go beyond the invasion of the renal cortex into nearby structures, including perirenal space, psoas major muscle, intestine, and abdominal wall.
View Article and Find Full Text PDFA Case of Cystic Retroperitoneal Dedifferentiated Liposarcoma Diagnosed by Percutaneous Image-Guided Biopsy.
Case Rep Oncol
November 2023
Department of Urology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
Introduction: Dedifferentiated liposarcoma (DDLP) was initially defined as a tumor containing differentiated liposarcoma and distinct regions of nonlipogenic spindle cell or pleomorphic sarcoma. Retroperitoneal liposarcomas feature a characteristic appearance with a predominantly fatty component, and cystic liposarcomas are rare. We describe a case of retroperitoneal DDLP predominantly consisting of multilocular cysts.
View Article and Find Full Text PDFMorphological characteristics of SETD2-mutated locally advanced clear cell renal cell carcinoma: Comparison with BAP1-mutated clear cell renal cell carcinoma.
Ann Diagn Pathol
February 2024
Department of Pathology, Genitourinary Pathology Center of Excellence, University of Pittsburgh Medical Center, Pittsburgh, USA.
Article Synopsis
- SETD2 and BAP1 are chromatin remodeling genes that are frequently mutated in clear cell renal cell carcinoma (ccRCC) and play a role in tumor progression and metastasis.
- A study compared 7 cases of locally advanced ccRCC with SETD2 mutations to 7 cases with BAP1 mutations, finding that SETD2-mutated tumors exhibited aggressive growth with a rhabdoid morphology and significant invasive characteristics.
- The study emphasizes the importance of molecular testing for SETD2 and BAP1 mutations in ccRCC for better risk assessment and treatment strategies, as their high-grade features can overlap, making it challenging to identify the mutations based solely on tumor appearance.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!